- Home
- SMTC vs CRNX Comparison
SMTC vs CRNX Comparison
Compare SMTC & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SMTC | CRNX |
|---|---|---|
| Founded | 1960 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.1B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SMTC | CRNX |
|---|---|---|
| Price | $79.14 | $49.12 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | ★ $73.47 | $71.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.2M |
| Earning Date | 11-24-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.33 | N/A |
| Revenue | ★ $1,026,622,000.00 | $1,535,000.00 |
| Revenue This Year | $17.67 | $425.31 |
| Revenue Next Year | $13.46 | $943.50 |
| P/E Ratio | $237.69 | ★ N/A |
| Revenue Growth | 20.60 | ★ 47.74 |
| 52 Week Low | $24.05 | $24.10 |
| 52 Week High | $81.32 | $60.34 |
Technical Indicators
Market Signals| Indicator | SMTC | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 63.27 | 68.12 |
| Support Level | $71.21 | $46.49 |
| Resistance Level | $81.32 | $49.29 |
| Average True Range (ATR) | 4.37 | 1.89 |
| MACD | 0.86 | 0.31 |
| Stochastic Oscillator | 87.33 | 95.05 |
Price Performance
Historical ComparisonAbout SMTC Semtech Corporation
Semtech Corp is engaged in designing, developing, manufacturing and marketing analog and mixed-signal semiconductors, algorithms and wireless semiconductors, connectivity modules, gateways, routers and connected services for IoT. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems and IoT Connected Services. The majority of the company's revenue is earned through Analog Mixed Signal and Wireless segment. Geographically majority of the company's revenue is earned from Asia Pacific region, company also operates in North America and Europe.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.